1. Home
  2. BLZE vs LCTX Comparison

BLZE vs LCTX Comparison

Compare BLZE & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLZE
  • LCTX
  • Stock Information
  • Founded
  • BLZE 2007
  • LCTX 1990
  • Country
  • BLZE United States
  • LCTX United States
  • Employees
  • BLZE N/A
  • LCTX N/A
  • Industry
  • BLZE Computer Software: Prepackaged Software
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BLZE Technology
  • LCTX Health Care
  • Exchange
  • BLZE Nasdaq
  • LCTX Nasdaq
  • Market Cap
  • BLZE 300.7M
  • LCTX 274.0M
  • IPO Year
  • BLZE 2021
  • LCTX N/A
  • Fundamental
  • Price
  • BLZE $8.22
  • LCTX $1.21
  • Analyst Decision
  • BLZE Strong Buy
  • LCTX Strong Buy
  • Analyst Count
  • BLZE 7
  • LCTX 5
  • Target Price
  • BLZE $10.21
  • LCTX $4.20
  • AVG Volume (30 Days)
  • BLZE 714.7K
  • LCTX 1.6M
  • Earning Date
  • BLZE 08-07-2025
  • LCTX 08-12-2025
  • Dividend Yield
  • BLZE N/A
  • LCTX N/A
  • EPS Growth
  • BLZE N/A
  • LCTX N/A
  • EPS
  • BLZE N/A
  • LCTX N/A
  • Revenue
  • BLZE $137,286,000.00
  • LCTX $10,914,000.00
  • Revenue This Year
  • BLZE $16.09
  • LCTX N/A
  • Revenue Next Year
  • BLZE $14.10
  • LCTX $244.95
  • P/E Ratio
  • BLZE N/A
  • LCTX N/A
  • Revenue Growth
  • BLZE 19.08
  • LCTX 76.43
  • 52 Week Low
  • BLZE $3.94
  • LCTX $0.37
  • 52 Week High
  • BLZE $8.25
  • LCTX $1.31
  • Technical
  • Relative Strength Index (RSI)
  • BLZE 77.63
  • LCTX 62.25
  • Support Level
  • BLZE $7.51
  • LCTX $1.15
  • Resistance Level
  • BLZE $8.05
  • LCTX $1.29
  • Average True Range (ATR)
  • BLZE 0.47
  • LCTX 0.08
  • MACD
  • BLZE 0.11
  • LCTX 0.02
  • Stochastic Oscillator
  • BLZE 99.04
  • LCTX 72.22

About BLZE Backblaze Inc.

Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage, which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and Other regions.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: